Delivery Order SPE2DB22D1017-SPE2DB24FG3YD

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Risperidone 0.5 mg tablets, with a ceiling value of $1,255.97 and a completion date of January 27, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,130.27, for the delivery of Risperidone 2 mg tablets. The contract has a completion date of June 12, 2025 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Risperdal 3 mg tablets. The $10,105.80 contract has an ultimate completion date of August 12, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to provide a wide range of medical commodities to federal agencies, including the military. This order is part of AmerisourceBergen's Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,384,072 units of Risperidone 1 mg tablets in 500-count packages. The firm-fixed-price delivery order has a ceiling value of $1,852.66 and a completion date of November 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $2,508.01 firm fixed-price delivery order is for the supply of 500 tablets of 0.25 mg risperidone, a medication used to treat mental health conditions. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Risperidone 2 mg tablets to the Defense Logistics Agency (DLA). The $3,333.72 firm fixed-price delivery order has a period of performance through July 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $3,339.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 60-count packages of 4mg risperidone tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of January 28, 2025 and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $2,074.06, is a firm fixed price delivery order for risperidone 1 mg oral disintegrating tablets. The contract was awarded on March 13, 2024, with an ultimate completion date of March 14, 2024. This award is a task order under an indefinite delivery contract (IDC) with a potential...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,859.42, is for the supply of Risperidone 1 mg tablets to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Risperidone 0.5 mg tablets. The delivery order, valued at $2,855.98, is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG3YD
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,558.00 fixed-price contract is for the delivery of 4,565,584,617 risperidone 3 mg tablets. This order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and civilian agencies to supply essential medications, supplies, and equipment to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 11/25/24, 9:27 AM